UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6‑K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a‑16 OR 15d‑16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
Report on Form 6‑K dated November 3, 2022
Commission File Number: 1‑13546
STMicroelectronics N.V.
(Name of
Registrant)
WTC Schiphol Airport
Schiphol Boulevard 265
1118 BH Schiphol Airport
The Netherlands
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20‑F or Form 40‑F:
Form 20‑F ☒Form 40‑F
☐
Indicate by check mark if the registrant is submitting the
Form 6‑K in paper as permitted by Regulation S‑T
Rule 101(b)(1):
Yes ☐No ☒
Indicate by check mark if the registrant is submitting the
Form 6‑K in paper as permitted by Regulation S‑T
Rule 101(b)(7):
Yes ☐No ☒
Indicate by check mark whether the registrant by furnishing the
information contained in this form is also thereby furnishing the
information to the Commission pursuant to
Rule 12g3‑2(b) under the Securities Exchange Act of
1934:
Yes ☐No ☒
If “Yes” is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3‑2(b): 82‑
__________
Enclosure: STMicroelectronics N.V.’s Nine months ended
October 1, 2022 Third Quarter and Nine Months ended October 1,
2022:
|
•
|
Operating and Financial Review and
Prospects;
|
|
•
|
Unaudited Interim Consolidated
Statements of Income, Statements of Comprehensive Income, Balance
Sheets, Statements of Cash Flow, and Statements of Equity and
related Notes for the three and nine months ended October 1, 2022;
and
|
|
•
|
Certifications pursuant to
Sections 302 (Exhibits 12.1 and 12.2) and 906
(Exhibit 13.1) of the Sarbanes‑Oxley Act of 2002, submitted to
the Commission on a voluntary basis.
|
OPERATING AND FINANCIAL REVIEW AND PROSPECTS
Overview
The following discussion should be read in conjunction with our
Unaudited Interim Consolidated Statements of Income, Statements of
Comprehensive Income, Balance Sheets, Statements of Cash Flows and
Statements of Equity for the three and nine months ended October 1,
2022 and Notes thereto included elsewhere in this Form 6‑K,
and our annual report on Form 20‑F for the year ended
December 31, 2021 as filed with the U.S. Securities and
Exchange Commission (the “Commission” or the “SEC”) on February 24,
2022 (the “Form 20‑F”). The following discussion contains
statements of future expectations and other forward‑looking
statements within the meaning of Section 27A of the Securities
Act of 1933, or Section 21E of the Securities Exchange Act of
1934, each as amended, particularly in the sections “Business
Overview” and “Liquidity and Capital Resources—Financial Outlook:
Capital Investment”. Our actual results may differ significantly
from those projected in the forward‑looking statements. For a
discussion of factors that might cause future actual results to
differ materially from our recent results or those projected in the
forward‑looking statements in addition to the factors set forth
below, see “Cautionary Note Regarding Forward‑Looking Statements”
and “Item 3. Key Information—Risk Factors” included in the
Form 20‑F. We assume no obligation to update the
forward‑looking statements or such risk factors.
Our Management’s Discussion and Analysis of Financial Position and
Results of Operations (“MD&A”) is provided in addition to the
accompanying Unaudited Interim Consolidated Financial Statements
(“Consolidated Financial Statements”) and notes to assist readers
in understanding our results of operations, financial condition and
cash flows. Our MD&A is organized as follows:
|
•
|
Critical Accounting Policies using
Significant Estimates.
|
|
•
|
Business Overview, a discussion of our
business and overall analysis of financial and other relevant
highlights for the three and nine months ended October 1,
2022, designed to provide context for the other sections of the
MD&A, including our expectations for selected financial items
for the fourth quarter of 2022.
|
|
•
|
Results of Operations, containing a
year-over-year and sequential analysis of our financial results for
the three and nine months ended October 1, 2022, as well as segment
information.
|
|
•
|
Discussion of the impact of changes in
exchange rates, interest rates and equity prices on our activity
and financial results.
|
|
•
|
Liquidity and Capital Resources,
presenting an analysis of changes in our balance sheets and cash
flows, and discussing our financial condition and potential sources
of liquidity.
|
|
•
|
Impact of Recently Issued U.S.
Accounting Standards.
|
|
•
|
Backlog and Customers, discussing the
level of backlog and sales to our key customers.
|
|
•
|
Disclosure Controls and
Procedures.
|
|
•
|
Cautionary Note Regarding
Forward-Looking Statements.
|
2
At STMicroelectronics N.V. (“ST” or the “Company”), we are 48,000
creators and makers of semiconductor technologies mastering the
semiconductor supply chain with state-of-the-art manufacturing
facilities. An independent device manufacturer, we work with more
than 200,000 customers and thousands of partners to design and
build products, solutions, and ecosystems that address their
challenges and opportunities, and the need to support a more
sustainable world. Our technologies enable smarter mobility, more
efficient power and energy management, and the wide-scale
deployment of the Internet of Things and connectivity. ST is
committed to becoming carbon neutral by 2027.
Critical Accounting Policies Using Significant Estimates
There were no significant changes in the first nine months of 2022
to the information provided under the heading “Critical Accounting
Policies Using Significant Estimates” included in our Form 20-F for
the year ended December 31, 2021, except for the impacts of the
application of the new guidance on convertible instruments, as
described in Note 5, Recent Accounting Pronouncements, of the
consolidated financial statements for the three and nine months
ended October 1, 2022.
Fiscal Year
Under Article 35 of our Articles of Association, our fiscal
year extends from January 1 to December 31. The first
quarter of 2022 ended on April 2, the second quarter ended on July
2 and the third quarter ended on October 1. The fourth quarter will
end on December 31, 2022. Based on our fiscal calendar, the
distribution of our revenues and expenses by quarter may be
unbalanced due to a different number of days in the various
quarters of the fiscal year and can also differ from equivalent
prior years’ periods, as illustrated in the below table for the
years 2021 and 2022.
|
Q1
|
Q2
|
Q3
|
Q4
|
|
Days
|
2021
|
93
|
91
|
91
|
90
|
2022
|
92
|
91
|
91
|
91
|
Business Overview
Our results of operations for each period were as follows:
|
|
Three Months Ended
|
|
|
% Variation
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
Sequential
|
|
|
Year
Over
Year
|
|
|
|
(In millions, except per share amounts)
|
|
|
|
|
|
|
|
|
|
Net revenues
|
|
$
|
4,321
|
|
|
$
|
3,837
|
|
|
$
|
3,197
|
|
|
|
12.6
|
%
|
|
|
35.2
|
%
|
Gross profit
|
|
|
2,059
|
|
|
|
1,819
|
|
|
|
1,330
|
|
|
|
13.2
|
|
|
|
54.7
|
|
Gross margin (as percentage of net revenues)
|
|
|
47.6
|
%
|
|
|
47.4
|
%
|
|
|
41.6
|
%
|
|
20 bps
|
|
|
600 bps
|
|
Operating income
|
|
|
1,272
|
|
|
|
1,004
|
|
|
|
605
|
|
|
|
26.7
|
|
|
|
110.1
|
|
Operating margin
|
|
|
29.4
|
%
|
|
|
26.2
|
%
|
|
|
18.9
|
%
|
|
320 bps
|
|
|
1,050 bps
|
|
Net income attributable to parent company
|
|
|
1,099
|
|
|
|
867
|
|
|
|
474
|
|
|
|
26.8
|
|
|
|
131.8
|
|
Earnings per share (Diluted)
|
|
$
|
1.16
|
|
|
$
|
0.92
|
|
|
$
|
0.51
|
|
|
|
26.1
|
%
|
|
|
127.5
|
%
|
(1)
|
Following a change in
U.S. GAAP reporting guidance effective January 1, 2022, net income
for the second and third quarter of 2022 does not include phantom
interests associated with convertible bonds. Prior year comparative
period has not been restated.
|
(2)
|
Diluted earnings per
share for the second and third quarter of 2022 include the full
dilutive effect of our outstanding convertible debt upon adoption
of the new U.S. GAAP reporting guidance on January 1, 2022. Prior
year comparative period has not been restated.
|
Our total available market is defined as “TAM”, while our
serviceable available market is defined as “SAM” and represents the
market for products sold by us (i.e., TAM excluding major devices
such as microprocessors, dynamic random-access memories,
optoelectronics devices other than optical sensors, flash memories,
consumer logic devices and wireless application specific products,
such as baseband and application processors).
Based on the data published by World Semiconductor Trade
Statistics, on a sequential basis, semiconductor industry revenues
in the third quarter of 2022 decreased by approximately 6% for our
TAM and increased by approximately 2% for our SAM to reach
approximately $141 billion and $73 billion, respectively. On a
year-over-year basis, our TAM decreased by approximately 3% and our
SAM increased by approximately 15%.
3
Our third quarter 2022 net revenues amounted to $4,321 million,
increasing 12.6% sequentially, about 210 basis points above the
mid-point of our released guidance, driven by continued strong
demand for our product portfolio. On a sequential basis, Automotive
and Discrete Group (ADG) revenues increased 7.5%, mainly driven by
higher sales in Automotive. Analog, Micro-Electro-Mechanical
Systems (“MEMS”) and Sensors Group (AMS) revenues increased 23.7%,
driven by higher Imaging revenues. Microcontrollers and Digital ICs
Group (MDG) revenues increased 8.8%, with both Microcontrollers and
RF Communications contributing to the increase.
On a year-over-year basis, third quarter net revenues increased
35.2% with higher net sales in all product groups and sub-groups.
ADG revenues increased 55.5% with both Automotive and Power
Discrete contributing to the increase. AMS revenues increased 9.7%,
with all sub-groups contributing and MDG revenues increased 47.7%
driven by higher sales in both RF Communications and
Microcontrollers.
Our revenue performance was above the performance of the SAM both
on a sequential and on a year-over-year basis.
Our effective average exchange rate for the third quarter of 2022
was $1.08 for €1.00, compared to $1.12 in the second quarter of
2022 and $1.19 for €1.00 in the third quarter of 2021. For a more
detailed discussion of our hedging transactions and the impact of
fluctuations in exchange rates, see “Impact of Changes in Exchange
Rates”.
Our third quarter of 2022 gross profit was $2,059 million and gross
margin was 47.6%, 60 basis points above the mid-point of our
guidance mainly thanks to a more favorable product mix and improved
manufacturing efficiency. On a sequential basis, gross margin
increased 20 basis points, mainly due to positive currency effects
and a more favorable product mix, partially offset by lower
manufacturing efficiency. Gross margin increased 600 basis points
year-over-year, principally due to favorable pricing and improved
product mix partially offset by the inflation of manufacturing
input costs.
Our aggregated selling, general & administrative (“SG&A”)
and research & development (“R&D”) expenses amounted to
$815 million, compared to $855 million and $757 million in the
prior and year-ago quarters, respectively. On a sequential basis,
operating expenses decreased, positively impacted by favorable
seasonality associated with higher vacation days and currency
effects, net of hedging. On a year-over-year basis, operating
expenses increased mainly due to higher cost of labor and higher
levels of activity in R&D programs, partially offset by
positive currency effects, net of hedging.
Other income and expenses, net, amounted to $28 million income,
decreasing by $12 million sequentially and $5 million on a
year-over-year basis, mainly due to lower public funding.
In the third quarter of 2022, our operating income was $1,272
million, equivalent to 29.4% of net revenues, compared to $1,004
million in the previous quarter (26.2% of net revenues), and to
$605 million (18.9% of net revenues) in the year-ago quarter. On a
sequential basis, operating income was positively impacted by the
combination of higher revenues and lower operating expenses. On a
year-over-year basis, the increase was mainly driven by the
combined effect of higher revenues and improved gross margin
profitability, partially offset by higher operating expenses.
In the third quarter of 2022, our cash and cash equivalents
decreased by $216 million, with net cash from operating activities
of $1,651 million. Capital expenditure payments for tangible and
intangible assets, net of proceeds from sales, were $975
million.
Our free cash flow, a non-U.S. GAAP measure, amounted to $676
million in the third quarter of 2022 compared to $420 million in
the third quarter of 2021. Refer to “Liquidity and Capital
Resources” for the reconciliation of the free cash flow, a non U.S.
GAAP measure, to our consolidated Statements of Cash Flows.
Looking at the third quarter, we expect a revenue increase of
approximately 1.8% sequentially, plus or minus 350 basis points.
Gross margin is expected to be approximately 47.3%, plus or minus
200 basis points.
This outlook is based on an assumed effective currency exchange
rate of approximately $1.03 = €1.00 for the fourth quarter of 2022
and includes the impact of existing hedging contracts. The fourth
quarter will close on December 31, 2022.
These are forward-looking statements that are subject to known and
unknown risks and uncertainties that could cause actual results to
differ materially; in particular, refer to those known risks and
uncertainties described in
4
“Cautionary Note Regarding Forward-Looking Statements” and
Item 3. “Key Information — Risk Factors” in our Form 20-F
as may be updated from time to time in our SEC filings.
Other Developments
On October 5, we announced
our plan to build an integrated Silicon Carbide (SiC) substrate
manufacturing facility in Italy to support the increasing demand
from our customers for SiC devices across automotive and industrial
applications. This facility, built at our Catania site in Italy
alongside the existing SiC device manufacturing facility, will be a
first of a kind in Europe for the production in volume of 150mm SiC
epitaxial substrates, integrating all steps in the production flow.
Production is expected to start in 2023, enabling a balanced supply
of SiC substrate between internal and merchant supply.
On August 24, we published our IFRS 2022 Semi Annual Accounts for
the six-month period ended July 2, 2022 on our website and filed
them with the Netherlands Authority for the Financial Markets
(Autoriteit Financiële
Markten).
5
Results of Operations
Segment Information
We design, develop, manufacture and market a broad range of
products, including discrete and standard commodity components,
application-specific integrated circuits (“ASICs”), full-custom
devices and semi-custom devices and application-specific standard
products (“ASSPs”) for analog, digital and mixed-signal
applications. In addition, we further participate in the
manufacturing value chain of smartcard products, which includes the
production and sale of both silicon chips and smartcards.
Our reportable segments are as follows:
|
•
|
Automotive
and
Discrete
Group
(ADG), comprised of dedicated automotive ICs, and
discrete and power transistor products.
|
|
•
|
Analog, MEMS
and Sensors
Group (AMS), comprised of analog, smart power, MEMS sensors
and actuators, and optical sensing solutions.
|
|
•
|
Microcontrollers
and
Digital
ICs
Group
(MDG), comprised of microcontrollers (general purpose
and secure), memories (NFC and EEPROM), and RF
Communications.
|
Effective July 1, 2022, the Low Power RF business unit was
transferred from the Analog, MEMS and Sensors Group (AMS) to the
Microcontrollers and Digital ICs Group (MDG). Prior periods have
been adjusted accordingly.
For the computation of the segments’ internal financial
measurements, we use certain internal rules of allocation for the
costs not directly chargeable to the segments, including cost of
sales, SG&A expenses and a part of R&D expenses. In
compliance with our internal policies, certain costs are not
allocated to the segments, but reported in “Others”. Those comprise
unused capacity charges, including reduced manufacturing activity
due to COVID-19 and incidents leading to power outage, impairment,
restructuring charges and other related closure costs, management
reorganization expenses, phase-out and start-up costs of certain
manufacturing facilities, and other unallocated income (expenses)
such as: strategic or special R&D programs, certain
corporate-level operating expenses, patent claims and litigations,
and other costs that are not allocated to product groups, as well
as operating earnings of other products. In addition, depreciation
and amortization expense is part of the manufacturing costs
allocated to the segments and is neither identified as part of the
inventory variation nor as part of the unused capacity charges;
therefore, it cannot be isolated in cost of sales. Finally, public
grants are allocated to our segments proportionally to the incurred
expenses on the sponsored projects.
Wafer costs are allocated to the segments based on actual cost.
From time to time, with respect to specific technologies, wafer
costs are allocated to segments based on market price.
6
Third
Quarter
2022
vs.
Second
Quarter 2022
and
Third
Quarter
2021
The following table sets forth certain financial data from our
Unaudited Interim Consolidated Statements of Income:
|
|
Three Months Ended
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
|
$ million
|
|
|
% of net
revenues
|
|
|
$ million
|
|
|
% of net
revenues
|
|
|
$ million
|
|
|
% of net
revenues
|
|
Net sales
|
|
$
|
4,305
|
|
|
|
99.6
|
%
|
|
$
|
3,830
|
|
|
|
99.8
|
%
|
|
$
|
3,192
|
|
|
|
99.8
|
%
|
Other revenues
|
|
|
16
|
|
|
|
0.4
|
|
|
|
7
|
|
|
|
0.2
|
|
|
|
5
|
|
|
|
0.2
|
|
Net revenues
|
|
|
4,321
|
|
|
|
100.0
|
|
|
|
3,837
|
|
|
|
100.0
|
|
|
|
3,197
|
|
|
|
100.0
|
|
Cost of sales
|
|
|
(2,262
|
)
|
|
|
(52.3
|
)
|
|
|
(2,018
|
)
|
|
|
(52.6
|
)
|
|
|
(1,867
|
)
|
|
|
(58.4
|
)
|
Gross profit
|
|
|
2,059
|
|
|
|
47.6
|
|
|
|
1,819
|
|
|
|
47.4
|
|
|
|
1,330
|
|
|
|
41.6
|
|
Selling, general and administrative
|
|
|
(352
|
)
|
|
|
(8.2
|
)
|
|
|
(366
|
)
|
|
|
(9.5
|
)
|
|
|
(324
|
)
|
|
|
(10.1
|
)
|
Research and development
|
|
|
(463
|
)
|
|
|
(10.7
|
)
|
|
|
(489
|
)
|
|
|
(12.7
|
)
|
|
|
(433
|
)
|
|
|
(13.5
|
)
|
Other income and expenses, net
|
|
|
28
|
|
|
|
0.6
|
|
|
|
40
|
|
|
|
1.0
|
|
|
|
33
|
|
|
|
0.9
|
|
Impairment, restructuring charges and other
related closure costs
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(1
|
)
|
|
|
—
|
|
Operating income
|
|
|
1,272
|
|
|
|
29.4
|
|
|
|
1,004
|
|
|
|
26.2
|
|
|
|
605
|
|
|
|
18.9
|
|
Interest income (expense), net
|
|
|
16
|
|
|
|
—
|
|
|
|
6
|
|
|
|
0.2
|
|
|
|
(8
|
)
|
|
|
(0.3
|
)
|
Other components of pension benefit costs
|
|
|
(2
|
)
|
|
|
—
|
|
|
|
(2
|
)
|
|
|
(0.1
|
)
|
|
|
(3
|
)
|
|
|
(0.1
|
)
|
Gain (loss) on financial instruments, net
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(45
|
)
|
|
|
(1.3
|
)
|
Income before income taxes and
noncontrolling interest
|
|
|
1,286
|
|
|
|
29.8
|
|
|
|
1,008
|
|
|
|
26.3
|
|
|
|
549
|
|
|
|
17.2
|
|
Income tax expense
|
|
|
(185
|
)
|
|
|
(4.3
|
)
|
|
|
(139
|
)
|
|
|
(3.6
|
)
|
|
|
(73
|
)
|
|
|
(2.3
|
)
|
Net income
|
|
|
1,101
|
|
|
|
25.5
|
|
|
|
869
|
|
|
|
22.6
|
|
|
|
476
|
|
|
|
14.9
|
|
Net (income) loss attributable to
noncontrolling interest
|
|
|
(2
|
)
|
|
|
—
|
|
|
|
(2
|
)
|
|
|
—
|
|
|
|
(2
|
)
|
|
|
—
|
|
Net income attributable to parent
company
|
|
$
|
1,099
|
|
|
|
25.4
|
%
|
|
$
|
867
|
|
|
|
22.6
|
%
|
|
$
|
474
|
|
|
|
14.8
|
%
|
Net revenues
|
|
Three Months Ended
|
|
|
% Variation
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
Sequential
|
|
|
Year
Over
Year
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
4,305
|
|
|
$
|
3,830
|
|
|
$
|
3,192
|
|
|
|
12.4
|
%
|
|
|
34.9
|
%
|
Other revenues
|
|
|
16
|
|
|
|
7
|
|
|
|
5
|
|
|
|
121.9
|
|
|
|
217.6
|
|
Net revenues
|
|
$
|
4,321
|
|
|
$
|
3,837
|
|
|
$
|
3,197
|
|
|
|
12.6
|
%
|
|
|
35.2
|
%
|
Sequentially, our third
quarter 2022 net revenues increased 12.6%, 210 basis points above
the mid-point of our released guidance, driven by continued strong
demand for our product portfolio. The sequential increase resulted
from higher average selling prices of approximately 8%, driven by a
more favorable product mix, and higher volumes of approximately
5%.
On a year-over-year basis, net revenues increased 35.2% as a result
of higher average selling prices of approximately 35%, driven by a
more favorable product mix and sales price increase.
7
Net revenues by product group
|
|
Three Months Ended
|
|
|
% Variation
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
Sequential
|
|
|
Year
Over
Year
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
ADG
|
|
$
|
1,563
|
|
|
$
|
1,454
|
|
|
$
|
1,005
|
|
|
|
7.5
|
%
|
|
|
55.5
|
%
|
AMS(1)
|
|
|
1,380
|
|
|
|
1,115
|
|
|
|
1,258
|
|
|
|
23.7
|
|
|
|
9.7
|
|
MDG(1)
|
|
|
1,374
|
|
|
|
1,263
|
|
|
|
930
|
|
|
|
8.8
|
|
|
|
47.7
|
|
Others
|
|
|
4
|
|
|
|
5
|
|
|
|
4
|
|
|
|
—
|
|
|
|
—
|
|
Total consolidated net revenues
|
|
$
|
4,321
|
|
|
$
|
3,837
|
|
|
$
|
3,197
|
|
|
|
12.6
|
%
|
|
|
35.2
|
%
|
(1)
|
Effective July 1, 2022,
the Low Power RF business unit was transferred from AMS to MDG.
Prior periods have been adjusted accordingly.
|
On a sequential basis, ADG revenues increased 7.5%, driven by
higher volumes of approximately 6% and higher average selling
prices of approximately 2%. AMS revenues increased 23.7%, due to
higher average selling prices of approximately 24%, thanks to a
better product mix. MDG revenues increased 8.8%, driven by higher
volumes of approximately 6% and higher average selling prices of
approximately 3%, due to a more favorable product mix.
On a year-over-year basis, ADG revenues increased 55.5%, driven by
higher average selling prices of approximately 54%, due to a better
product mix and higher selling prices, and higher volumes of
approximately 2%. AMS revenues increased 9.7% compared to the
year-ago period, driven by higher average selling prices of
approximately 20%, mainly due to a better product mix, partially
offset by lower volumes of approximately 10%. MDG revenues
increased 47.7%, due to higher average selling prices of
approximately 37%, due to a better product mix and higher selling
prices, and higher volumes of approximately 11%.
Net Revenues by Market Channel (1)
|
|
Three Months Ended
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
OEM
|
|
|
67
|
%
|
|
|
65
|
%
|
|
|
68
|
%
|
Distribution
|
|
|
33
|
|
|
|
35
|
|
|
|
32
|
|
Total consolidated net revenues
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
(1)
|
Original Equipment Manufacturers (“OEM”) are the end-customers to
which we provide direct marketing application engineering support,
while Distribution refers to the distributors and representatives
that we engage to distribute our products around the world.
|
By market channel, our third quarter net revenues in Distribution
amounted to 33% of our total consolidated revenues, decreasing from
35% and increasing from 32% in the prior and year-ago quarter,
respectively.
Net Revenues by Location of Shipment (1)
|
|
Three Months Ended
|
|
|
% Variation
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
Sequential
|
|
|
Year
Over
Year
|
|
|
|
(In millions)
|
|
|
|
|
|
Europe, Middle East, Africa ("EMEA")
|
|
$
|
936
|
|
|
$
|
826
|
|
|
$
|
578
|
|
|
|
13.3
|
%
|
|
|
61.9
|
%
|
Americas
|
|
|
586
|
|
|
|
562
|
|
|
|
360
|
|
|
|
4.3
|
|
|
|
62.8
|
|
Asia Pacific
|
|
|
2,799
|
|
|
|
2,449
|
|
|
|
2,259
|
|
|
|
14.3
|
|
|
|
23.9
|
|
Total consolidated net revenues
|
|
$
|
4,321
|
|
|
$
|
3,837
|
|
|
$
|
3,197
|
|
|
|
12.6
|
%
|
|
|
35.2
|
%
|
(1)
|
Net revenues by location of shipment
are classified by location of customer invoiced or reclassified by
shipment destination in line with customer demand. For example,
products ordered by U.S.‑based companies to be invoiced to Asia
Pacific affiliates are classified as Asia Pacific revenues.
Furthermore, the comparison among the different periods may be
affected by shifts in shipments from one location to another, as
requested by our customers.
|
On a sequential basis, EMEA revenues grew 13.3%, mainly due to
higher sales in Microcontrollers and Automotive. Americas revenues
grew 4.3%, mainly due to higher sales in Microcontrollers and RF
Communications. Asia Pacific revenues increased 14.3%, mainly
driven by higher sales in Imaging and Automotive.
8
On a year-over-year basis, all regions registered double-digits
revenue growth. EMEA revenues grew
61.9%,
mainly driven by higher sales in
Automotive and
Microcontrollers. Americas revenues increased
62.8%,
mainly due to higher sales
in
Microcontrollers,
Automotive and RF Communications.
Asia Pacific revenues increased
23.9%,
mainly
due to
higher sales in
Automotive and
Microcontrollers.
Gross profit
|
|
Three Months Ended
|
|
|
Variation
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
Sequential
|
|
|
Year
Over
Year
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
$
|
2,059
|
|
|
$
|
1,819
|
|
|
$
|
1,330
|
|
|
|
13.2
|
%
|
|
|
54.7
|
%
|
Gross margin
(as percentage of net revenues)
|
|
|
47.6
|
%
|
|
|
47.4
|
%
|
|
|
41.6
|
%
|
|
20 bps
|
|
|
600 bps
|
|
In the third quarter of 2022, gross margin was 47.6%, 60 basis
points above the mid-point of our guidance, mainly thanks to a more
favorable product mix and improved manufacturing efficiency. On a
sequential basis, gross margin increased 20 basis points, mainly
due to positive currency effects and a more favorable product mix,
partially offset by lower manufacturing efficiency.
On a year-over-year basis, gross margin increased 600 basis points,
principally due to favorable pricing and improved product mix
partially offset by the inflation of manufacturing input costs.
Operating expenses
|
|
Three Months Ended
|
|
|
Variation
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
Sequential
|
|
|
Year
Over
Year
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
$
|
(352
|
)
|
|
$
|
(366
|
)
|
|
$
|
(324
|
)
|
|
|
(3.8
|
)%
|
|
|
8.6
|
%
|
Research and development
|
|
|
(463
|
)
|
|
|
(489
|
)
|
|
|
(433
|
)
|
|
|
(5.3
|
)
|
|
|
7.0
|
|
Total operating expenses
|
|
$
|
(815
|
)
|
|
$
|
(855
|
)
|
|
$
|
(757
|
)
|
|
|
(4.7
|
)%
|
|
|
7.7
|
%
|
As percentage of net revenues
|
|
|
18.9
|
%
|
|
|
22.3
|
%
|
|
|
23.6
|
%
|
|
-340 bps
|
|
|
-470 bps
|
|
On a sequential basis, operating expenses decreased, positively
impacted by favorable seasonality associated with higher vacation
days and currency effects, net of hedging. On a year-over-year
basis, operating expenses increased mainly due to higher cost of
labor and higher levels of activity in R&D programs, partially
offset by positive currency effects, net of hedging.
As a percentage of net revenues, our operating expenses amounted to
18.9% in the third quarter of 2022, decreasing compared to 22.3% in
the prior quarter and 23.6% in the year-ago quarter.
R&D expenses were net of research tax credits, which amounted
to $24 million in the third quarter of 2022, compared to $27
million and $31 million, in the prior and year-ago quarters,
respectively.
Other income and expenses, net
|
|
Three Months Ended
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
|
(In millions)
|
|
Public funding
|
|
$
|
28
|
|
|
$
|
39
|
|
|
$
|
39
|
|
Exchange gain (loss), net
|
|
|
6
|
|
|
|
5
|
|
|
|
2
|
|
Start-up and phase-out costs
|
|
|
(1
|
)
|
|
|
(1
|
)
|
|
|
—
|
|
Patent costs
|
|
|
(3
|
)
|
|
|
(1
|
)
|
|
|
(2
|
)
|
Gain on sale of non-current assets
|
|
|
—
|
|
|
|
2
|
|
|
|
2
|
|
COVID-19 incremental costs
|
|
|
(1
|
)
|
|
|
(3
|
)
|
|
|
(5
|
)
|
Other, net
|
|
|
(1
|
)
|
|
|
(1
|
)
|
|
|
(3
|
)
|
Other income and expenses, net
|
|
$
|
28
|
|
|
$
|
40
|
|
|
$
|
33
|
|
As percentage of net revenues
|
|
|
0.6
|
%
|
|
|
1.0
|
%
|
|
|
0.9
|
%
|
9
In the third quarter of 2022, other income and expenses, net,
amounted to $28 million income, decreasing by $12 million
sequentially and $5 million on a year-over-year basis, mainly due
to lower public funding.
Impairment, restructuring charges and other related closure
costs
|
|
Three Months Ended
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
|
(In millions)
|
|
Impairment, restructuring charges and other related closure
costs
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(1
|
)
|
There are no pending restructuring initiatives in 2022.
In the third quarter of 2021, we recorded $1 million of impairment,
restructuring charges and other related closure costs, related to
the impairment charge on licenses with no alternative future
use.
Operating income
|
|
Three Months Ended
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
|
(In millions)
|
|
Operating income
|
|
$
|
1,272
|
|
|
$
|
1,004
|
|
|
$
|
605
|
|
As percentage of net revenues
|
|
|
29.4
|
%
|
|
|
26.2
|
%
|
|
|
18.9
|
%
|
In the third quarter of 2022, operating income was $1,272 million,
compared to an operating income of $1,004 million and $605 million
in the prior and year-ago quarters, respectively.
On a sequential basis, operating income was positively impacted by
the combination of higher revenues and lower operating
expenses.
On a year-over-year basis, the increase was mainly driven by the
combined effect of higher revenues and improved gross margin
profitability, partially offset by higher operating expenses.
Operating income by product group
|
|
Three Months Ended
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
|
$ million
|
|
|
% of net
revenues
|
|
|
$ million
|
|
|
% of net
revenues
|
|
|
$ million
|
|
|
% of net
revenues
|
|
ADG
|
|
$
|
404
|
|
|
|
25.9
|
%
|
|
$
|
359
|
|
|
|
24.7
|
%
|
|
$
|
108
|
|
|
|
10.8
|
%
|
AMS(1)
|
|
|
376
|
|
|
|
27.2
|
|
|
|
269
|
|
|
|
24.1
|
|
|
|
305
|
|
|
|
24.3
|
|
MDG(1)
|
|
|
504
|
|
|
|
36.7
|
|
|
|
425
|
|
|
|
33.6
|
|
|
|
219
|
|
|
|
23.5
|
|
Total operating income of product groups
|
|
|
1,284
|
|
|
|
29.7
|
|
|
|
1,053
|
|
|
|
27.5
|
|
|
|
632
|
|
|
|
19.8
|
|
Others(2)
|
|
|
(12
|
)
|
|
|
—
|
|
|
|
(49
|
)
|
|
|
—
|
|
|
|
(27
|
)
|
|
|
—
|
|
Total consolidated operating income
|
|
$
|
1,272
|
|
|
|
29.4
|
%
|
|
$
|
1,004
|
|
|
|
26.2
|
%
|
|
$
|
605
|
|
|
|
18.9
|
%
|
(1)
|
Effective July 1, 2022,
the Low Power RF business unit was transferred from AMS to MDG.
Prior periods have been adjusted accordingly.
|
(2)
|
Operating income (loss)
of Others includes items such as unused capacity charges, including
reduced manufacturing activity due to COVID-19 and incidents
leading to power outage, impairment, restructuring charges and
other related closure costs, management reorganization costs,
phase-out and start-up costs of certain manufacturing facilities,
and other unallocated income (expenses) such as: strategic or
special R&D programs, certain corporate level operating
expenses, patent claims and litigations, and other costs that are
not allocated to product groups, as well as operating earnings of
other products.
|
For the third quarter of 2022, ADG operating income was $404
million, increasing sequentially by $45 million mainly driven by
higher profitability in Automotive. AMS operating income was $376
million, increasing sequentially by $107 million, mainly thanks to
higher profitability in Imaging. MDG operating income increased by
$79 million sequentially, reaching $504 million, driven by both
Microcontrollers and RF Communications.
ADG operating income increased by $296 million year-over-year
reflecting higher profitability in both Automotive and Power
Discrete. AMS operating income increased by $71 million, with
Analog and MEMS contributing to the increase. MDG operating income
increased by $285 million, driven by both Microcontrollers and RF
Communications higher profitability.
10
Reconciliation to consolidated operating income
|
|
Three Months Ended
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
|
(In millions)
|
|
Total operating income of product groups
|
|
$
|
1,284
|
|
|
$
|
1,053
|
|
|
$
|
632
|
|
Impairment, restructuring charges and other related closure
costs
|
|
|
—
|
|
|
|
—
|
|
|
|
(1
|
)
|
Start-up and phase-out costs
|
|
|
(1
|
)
|
|
|
(1
|
)
|
|
|
—
|
|
Unused capacity charges
|
|
|
—
|
|
|
|
(13
|
)
|
|
|
(14
|
)
|
Other unallocated manufacturing results
|
|
|
(8
|
)
|
|
|
(33
|
)
|
|
|
(6
|
)
|
Gain on sale of non-current assets
|
|
|
—
|
|
|
|
2
|
|
|
|
2
|
|
Strategic and R&D programs
and other non-allocated provisions(1)
|
|
|
(3
|
)
|
|
|
(4
|
)
|
|
|
(8
|
)
|
Total operating income (loss) of Others
|
|
|
(12
|
)
|
|
|
(49
|
)
|
|
|
(27
|
)
|
Total consolidated operating income
|
|
$
|
1,272
|
|
|
$
|
1,004
|
|
|
$
|
605
|
|
(1)
|
Includes unallocated income and
expenses such as certain corporate-level operating expenses and
other income (costs) that are not allocated to the product
segments.
|
Interest income (expense), net
|
|
Three Months Ended
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
|
(In millions)
|
|
Interest income (expense), net
|
|
$
|
16
|
|
|
$
|
6
|
|
|
$
|
(8
|
)
|
In the third quarter of 2022, we recorded a net interest income of
$16 million, compared to a net interest income of $6 million in the
prior quarter and a net interest expense of $8 million in the
year-ago quarter. The third quarter net interest income was
composed of $19 million of interest income, partially offset by
interest expense on borrowings and banking fees of $3 million.
On January 1, 2022, we adopted the new U.S. GAAP reporting guidance
on distinguishing liabilities from equity and EPS, by applying the
modified retrospective method, under which prior year periods are
not restated. Interest expense recorded in the year ago quarter
included a charge of $8 million related to the outstanding senior
unsecured convertible bonds, mainly resulting from the non-cash
accretion expense, as recorded under the previous accounting
guidance. With the adoption of the new guidance, the finance cost
of the convertible debt instruments outstanding at the date of
adoption is limited to the amortization expense of debt issuance
costs.
Gain (loss) on financial instruments, net
|
|
Three Months Ended
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
|
(In millions)
|
|
Gain (loss) on financial instruments, net
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(45
|
)
|
During the third quarter of 2022, no significant gain or loss on
financial instruments was recorded.
During the third quarter of 2021, we recorded a $45 million loss
generated on the settlement of Tranche B of our 2017 Senior
Unsecured Convertible Bonds. This loss was associated with the fair
value measurement of the liability component of Tranche B upon
settlement and the write-off of unamortized debt issuance
costs.
Income tax expense
|
|
Three Months Ended
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
|
(In millions)
|
|
Income tax expense
|
|
$
|
(185
|
)
|
|
$
|
(139
|
)
|
|
$
|
(73
|
)
|
During the third quarter of 2022, we registered an income tax
expense of $185 million, reflecting a 14.6% estimated annual
effective tax rate before discrete items at consolidated level,
applied to the first nine months of 2022 consolidated income before
income tax, consistent with the actual annual tax rate of 2021.
11
Net income attributable to parent company
|
|
Three Months Ended
|
|
|
|
October 1,
2022
|
|
|
July 2,
2022
|
|
|
October 2,
2021
|
|
|
|
(In millions)
|
|
Net income attributable to parent company
|
|
$
|
1,099
|
|
|
$
|
867
|
|
|
$
|
474
|
|
As percentage of net revenues
|
|
|
25.4
|
%
|
|
|
22.6
|
%
|
|
|
14.8
|
%
|
For the third quarter of 2022, we reported net income of
$1,099 million, representing diluted earnings per share of
$1.16, compared to $0.92 in the prior quarter and $0.51 in the
prior-year quarter.
Diluted earnings per share for the third quarter of 2022 includes
the full dilutive effect of our outstanding convertible debt upon
adoption of the newly applicable U.S. GAAP reporting guidance on
January 1, 2022. Prior year period has not been restated.
12
Nine Months of 2022 vs. Nine Months of 2021
The following table sets forth certain financial data from our
Unaudited Interim Consolidated Statements of Income:
|
|
Nine Months Ended
|
|
|
|
October 1,
2022
|
|
|
October 2,
2021
|
|
|
|
$ million
|
|
|
% of net
revenues
|
|
|
$ million
|
|
|
% of net
revenues
|
|
Net sales
|
|
$
|
11,675
|
|
|
|
99.8
|
%
|
|
$
|
9,187
|
|
|
|
99.8
|
%
|
Other revenues
|
|
|
29
|
|
|
|
0.2
|
|
|
|
18
|
|
|
|
0.2
|
|
Net revenues
|
|
|
11,704
|
|
|
|
100.0
|
|
|
|
9,205
|
|
|
|
100.0
|
|
Cost of sales
|
|
|
(6,171
|
)
|
|
|
(52.7
|
)
|
|
|
(5,488
|
)
|
|
|
(59.6
|
)
|
Gross profit
|
|
|
5,533
|
|
|
|
47.3
|
|
|
|
3,717
|
|
|
|
40.4
|
|
Selling, general and administrative
|
|
|
(1,076
|
)
|
|
|
(9.2
|
)
|
|
|
(972
|
)
|
|
|
(10.6
|
)
|
Research and development
|
|
|
(1,429
|
)
|
|
|
(12.2
|
)
|
|
|
(1,321
|
)
|
|
|
(14.4
|
)
|
Other income and expenses, net
|
|
|
125
|
|
|
|
1.1
|
|
|
|
109
|
|
|
|
1.3
|
|
Impairment, restructuring charges and other
related closure costs
|
|
|
—
|
|
|
|
—
|
|
|
|
1
|
|
|
|
—
|
|
Operating income
|
|
|
3,153
|
|
|
|
26.9
|
|
|
|
1,534
|
|
|
|
16.7
|
|
Interest income (expense), net
|
|
|
24
|
|
|
|
0.2
|
|
|
|
(24
|
)
|
|
|
(0.3
|
)
|
Other components of pension benefit costs
|
|
|
(7
|
)
|
|
|
(0.1
|
)
|
|
|
(8
|
)
|
|
|
(0.1
|
)
|
Gain (loss) on financial instruments, net
|
|
|
—
|
|
|
|
—
|
|
|
|
(43
|
)
|
|
|
(0.4
|
)
|
Income before income taxes and
noncontrolling interest
|
|
|
3,170
|
|
|
|
27.1
|
|
|
|
1,459
|
|
|
|
15.9
|
|
Income tax expense
|
|
|
(454
|
)
|
|
|
(3.9
|
)
|
|
|
(204
|
)
|
|
|
(2.3
|
)
|
Net income
|
|
|
|